Using the Bayesian credible subgroups method to identify populations benefiting from treatment: An application to the Look AHEAD trial.
Traditionally, subgroup analyses are used to assess whether patient characteristics moderate treatment effectiveness with general disregard for issues of multiplicity. Using data from The Action for Health in Diabetes (Look AHEAD) trial in the United States, we aim to identify a subgroup where all o...
Main Authors: | Anna Coonan, Patrick Schnell, Joel Smith, John Forbes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0231241 |
Similar Items
-
Bayesian credible subgroup identification for treatment effectiveness in time-to-event data.
by: Duy Ngo, et al.
Published: (2020-01-01) -
Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics
by: Behrmann Jason
Published: (2007-07-01) -
Looking back……looking ahead
by: Neena S Sawant
Published: (2017-01-01) -
Looking back...looking ahead
by: Udwadia Tehemton
Published: (2010-01-01) -
Looking ahead to 2021
by: Fares S. Haddad
Published: (2021-01-01)